Results 271 to 280 of about 133,463 (299)

Transient MEK Inhibitor-Associated Retinopathy in Metastatic Melanoma

Annals of Oncology, 2014
Reinhard Dummer, Simone M. Goldinger, Martin Urner   +2 more
exaly  

Titration of Signalling Output: Insights Into Clinical Combinations of MEK and AKT Inhibitors

Annals of Oncology, 2015
Johann de Bono, Udai Banerji, J S de Bono   +2 more
exaly  

MEK

2007
openaire   +2 more sources

Ocular Toxicities of MEK Inhibitors and Other Targeted Therapies

Annals of Oncology, 2016
Philippe L. Bedard, P L Bedard
exaly  

KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS

Cell, 2018
Marzia Capelletti, Haiyun Wang, Sudershan Gondi   +2 more
exaly  

Structural Basis for the Action of the Drug Trametinib at KSR-Bound MEK

Nature, 2020
Zaigham M Khan, Arvin C Dar, Jayasudhan Reddy Yerabolu   +2 more
exaly  

MEK MUTATIONS CONFERRING RESISTANCE TO MEK INHIBITORS

2010
GARRAWAY LEVI, EMERY CAROLINE, GARCIA-ECHEVERRIA CARLOS   +2 more
openaire   +5 more sources

MEK ligands and polynucleotides encoding MEK ligands

2008
BACHINSKY DAVID, CARSON JONATHAN, ATZEL AMY, REED THOMAS   +3 more
openaire   +8 more sources

A Phase IB Trial of the Oral MEK Inhibitor Trametinib (GSK1120212) in Combination With Everolimus in Patients With Advanced Solid Tumors

Annals of Oncology, 2015
J R Infante, K P Papadopoulos, J C Bendell   +2 more
exaly  

INHIBITORS OF MEK

2008
KOH YUNG-HYO, HONG ZHI, VERNIER JEAN-MICHEL, MADERNA ANDREAS   +3 more
openaire   +4 more sources